Catherine Dargan, partner, Covington & Burling LLP, and one of the 2021 Top 25 Most Influential Women in Mid-Market M&A, discusses Covid-related deals, leading her firm’s response to the pandemic and nurturing diversity, equity and inclusion in the middle market.
Dargan recently advised Merck & Co. Inc. (NYSE: MRK) on its acquisition of OncoImmune, a biopharmaceutical company focused on Covid treatment. Watch the video interview, which was featured at M&A’s Most Influential Women Speak virtual event on Feb. 24. For more, see The 2021 Top 25 Most Influential Women in Mid-Market M&A.
